
|Articles|December 1, 2013
- Applied Clinical Trials-12-01-2013
- Volume 22
- Issue 12
Act Cover
S
Advertisement
Cover
Articles in this issue
almost 12 years ago
On Trial—Europe's Response to Antibiotic Research Gapalmost 12 years ago
Clinical Trial Design Automationalmost 12 years ago
Clinical Supply Issues Challenge Sponsors and Patientsalmost 12 years ago
Reasons for Clinical Failures by Phasealmost 12 years ago
Clearing the Way for the Internet of Thingsalmost 12 years ago
Developing a Successful Peer-to-Peer Mentoring Programalmost 12 years ago
Clinical Technologiesalmost 12 years ago
Jury's Still Out on How Best to Handle Trial Dataalmost 12 years ago
Exciting Changes for Applied Clinical Trials in 2014almost 12 years ago
Training and EducationNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Using AI and Tokenized Data to Match Patients to Protocols
3
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5





.png)



.png)



.png)
.png)
